{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:14:10Z","timestamp":1791519250493,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004850","name":"Tokat Gaziosmanpa\u015fa University","doi-asserted-by":"publisher","award":["2017\/80"],"award-info":[{"award-number":["2017\/80"]}],"id":[{"id":"10.13039\/501100004850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbrc.2023.06.015","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T20:46:24Z","timestamp":1688762784000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10\u00a0A\/B, and induces TRAIL-mediated cell death in colorectal cancer cells"],"prefix":"10.1016","volume":"675","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-194X","authenticated-orcid":false,"given":"Feyzanur","family":"Caldiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-5157","authenticated-orcid":false,"given":"Caglar","family":"Berkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-2359","authenticated-orcid":false,"given":"Burak","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslihan Hatun","family":"Cacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senol","family":"Citli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-9493","authenticated-orcid":false,"given":"Ercan","family":"Cacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bbrc.2023.06.015_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrc.2023.06.015_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154007","article-title":"RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma","volume":"236","author":"Caldiran","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.bbrc.2023.06.015_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5505\/TurkHijyen.2017.12499","article-title":"Enhancing sensitivity of chemoresistant ovarian cancer cells to TRAIL and FAS mediated apoptosis by radiation","volume":"74","author":"Cacan","year":"2017","journal-title":"Turkish Bull. Hyg. Exp. Biol."},{"issue":"25","key":"10.1016\/j.bbrc.2023.06.015_bib4","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1038\/sj.onc.1206520","article-title":"TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB","volume":"22","author":"Ehrhardt","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2023.06.015_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1158\/1535-7163.MCT-07-0167","article-title":"TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib","volume":"6","author":"Voortman","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"issue":"6","key":"10.1016\/j.bbrc.2023.06.015_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1074-7613(00)80401-X","article-title":"TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB","volume":"7","author":"Schneider","year":"1997","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bbrc.2023.06.015_bib7","doi-asserted-by":"crossref","first-page":"30405","DOI":"10.3390\/ijms161226238","article-title":"Combination treatment with sublethal ionizing radiation and the proteasome inhibitor, bortezomib, enhances death-receptor mediated apoptosis and anti-tumor immune attack","volume":"16","author":"Cacan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.06.015_bib8","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/cells11233717","article-title":"Targeting TRAIL death receptors in triple-negative breast cancers: challenges and strategies for cancer therapy","volume":"11","author":"Kundu","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.bbrc.2023.06.015_bib9","first-page":"579","article-title":"TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells","volume":"47","author":"Szliszka","year":"2009","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.bbrc.2023.06.015_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3389\/fimmu.2019.01530","article-title":"Multiple interactions between cancer cells and the tumor microenvironment modulate TRAIL signaling: implications for TRAIL receptor targeted therapy","volume":"10","author":"de Looff","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbrc.2023.06.015_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.bbrc.2023.06.015_bib12","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1517\/14656566.2014.965142","article-title":"Bortezomib for the treatment of non-Hodgkin's lymphoma","volume":"15","author":"Bose","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.bbrc.2023.06.015_bib13","first-page":"115","article-title":"The effect of olaparib and bortezomib combination treatment on ovarian cancer cell lines","volume":"79","author":"Berkel","year":"2020","journal-title":"Eur. J. Biol."},{"issue":"11","key":"10.1016\/j.bbrc.2023.06.015_bib14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.7150\/ijms.34398","article-title":"Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL","volume":"16","author":"Bui","year":"2019","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2023.06.015_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/biom12010051","article-title":"Progress on the application of bortezomib and bortezomib-based nanoformulations","volume":"12","author":"Liu","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.bbrc.2023.06.015_bib16","first-page":"369","article-title":"Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. The Lancet","volume":"6","author":"Reni","year":"2005","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.bbrc.2023.06.015_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/1120009X.2020.1740389","article-title":"Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells","volume":"32","author":"Cacan","year":"2020","journal-title":"J.\u00a0Chemother."},{"issue":"3","key":"10.1016\/j.bbrc.2023.06.015_bib18","first-page":"407","article-title":"Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts","volume":"4","author":"Xu","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2023.06.015_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628332","article-title":"The TRAIL in the treatment of human cancer: an update on clinical trials","volume":"8","author":"Snajdauf","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"10.1016\/j.bbrc.2023.06.015_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.bbrc.2023.06.015_bib21","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.06.015_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"20","key":"10.1016\/j.bbrc.2023.06.015_bib23","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2023.06.015_bib24","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2023.06.015_bib25","doi-asserted-by":"crossref","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Briefings Bioinf."},{"issue":"5","key":"10.1016\/j.bbrc.2023.06.015_bib26","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1007\/s11033-021-06404-y","article-title":"Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents","volume":"48","author":"Kucuk","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.bbrc.2023.06.015_bib27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/cancers11101469","article-title":"The role of TRAIL\/DRs in the modulation of immune cells and responses","volume":"11","author":"Sag","year":"2019","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.bbrc.2023.06.015_bib28","doi-asserted-by":"crossref","first-page":"11108","DOI":"10.1074\/jbc.M115.645333","article-title":"DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells","volume":"290","author":"Li","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.06.015_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-9966-33-3","article-title":"Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells","volume":"33","author":"Zhao","year":"2014","journal-title":"J.\u00a0Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.bbrc.2023.06.015_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2023.06.015_bib31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12885-018-4352-3","article-title":"The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells","volume":"18","author":"Ryu","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bbrc.2023.06.015_bib32","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/1535-7163.MCT-07-2444","article-title":"Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells","volume":"7","author":"Li","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"issue":"3","key":"10.1016\/j.bbrc.2023.06.015_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02893359","article-title":"Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac\/DIABLO from the mitochondria","volume":"12","author":"Nagy","year":"2006","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbrc.2023.06.015_bib34","first-page":"949","article-title":"Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer","volume":"20","author":"Wu","year":"2002","journal-title":"Int. J. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23007520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23007520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:47:45Z","timestamp":1762094865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23007520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"alternative-id":["S0006291X23007520"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.06.015","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10\u00a0A\/B, and induces TRAIL-mediated cell death in colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}